Save time and get answers to complex questions with AI chat
Adefovir dipivoxil discount cardIs liver function monitoring necessary with lipitorEnhertu loss of exclusivity patent expirationOzempic jordan price 2026Nicardipine brand names
See the DrugPatentWatch profile for Alteplase
Alteplase is classified as a thrombolytic (fibrinolytic) medicine—specifically a tissue plasminogen activator (tPA). It works by activating plasminogen to help break down blood clots.
As a recombinant form of human tPA, alteplase promotes conversion of plasminogen into plasmin, which degrades fibrin in a clot. This is why it’s used for acute, time-sensitive thrombotic conditions such as ischemic stroke and certain forms of vascular thrombosis.
People use “classification” in a few different ways: - Therapeutic/clinical class: thrombolytic (tPA) - Mechanism-based description: tissue plasminogen activator - Coding systems (like ATC): varies by country and the exact product labeling If you tell me whether you need the ATC code (or another system like FDA/USP classification), I can format the answer to match that system.
Other Questions About Alteplase :